• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PROMUS ELEMENT PLUS; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PROMUS ELEMENT PLUS; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number 9392
Device Problems Obstruction of Flow (2423); Material Deformation (2976)
Patient Problem Thrombosis (2100)
Event Date 02/15/2020
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.
 
Event Description
It was reported that thrombosis and stent damage occurred.Vascular access was obtained via the femoral artery.The 95% stenosed, 60mmx2.75mm, eccentric, de novo target lesion was located in the ostial and proximal right coronary artery.After a pt2 ls guidewire was placed, the target lesion was predilated with a 2.5x 20mm emerge balloon.A 2.50x32mm promus element plus drug-eluting stent was implanted in the target lesion.A 2.75x32mm promus element plus drug-eluting stent was also advanced for treatment.However, during positioning, the stent stopped outside of the ostium into the aorta and there was no back flow.When the 2.75x32mm device was removed, it was noted that the catheter was full of thrombi and that the stent had a distorted configuration.The procedure was completed with another 2.75x32mm promus element plus.There were no further patient complications and the patient's status was stable.
 
Event Description
It was reported that thrombosis and stent damage occurred.Vascular access was obtained via the femoral artery.The 95% stenosed, 60mmx2.75mm, eccentric, de novo target lesion was located in the ostial and proximal right coronary artery.After a pt2 ls guidewire was placed, the target lesion was predilated with a 2.5x 20mm emerge balloon.A 2.50x32mm promus element plus drug-eluting stent was implanted in the target lesion.A 2.75x32mm promus element plus drug-eluting stent was also advanced for treatment.However, during positioning, the stent stopped outside of the ostium into the aorta and there was no back flow.When the 2.75x32mm device was removed, it was noted that the catheter was full of thrombi and that the stent had a distorted configuration.The procedure was completed with another 2.75x32mm promus element plus.There were no further patient complications and the patient's status was stable.
 
Manufacturer Narrative
Device is a combination product: device evaluated by mfr.: promus element plus,mr,ous 2.75 x 32 mm stent delivery system catheter was returned for analysis.An examination visual and via scope of the crimped stent found stent damage.Stent struts from the proximal end of the stent were noted to be lifted from their crimped position and slightly flared opened around the proximal balloon cone and pulled distally.Stent struts form the distal end of the stent noted to be lifted and slightly flared (opened) around the distal balloon cone.The undamaged crimped stent outer diameter was measured and the result was within max crimped stent profile measurement.The balloon was reviewed and both proximal and distal balloon cone appeared slightly inflated with the balloon wings not tightly wrapped and folded.The balloon cones show signs of some positive pressure applied to them.A visual and microscopic examination of the bumper tip showed no signs of damage.A visual and tactile examination of the hypotube shaft found no issues.A visual and tactile examination of the outer and mid-shaft section and a visual examination of the inner lumen found no issues along the shaft polymer extrusion.No other issues were identified during the product analysis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT PLUS
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key9733510
MDR Text Key180583874
Report Number2134265-2020-01829
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 05/04/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/29/2021
Device Model Number9392
Device Catalogue Number9392
Device Lot Number0023777678
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/09/2020
Initial Date Manufacturer Received 02/15/2020
Initial Date FDA Received02/20/2020
Supplement Dates Manufacturer Received04/08/2020
Supplement Dates FDA Received05/04/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age70 YR
Patient Weight80
-
-